Skip to content

CAM and cancer

Comparion of aromatherapy with essential oils of Lavender and Rose on sleep quality in patients undergoing chemotherapy

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017061134457N1
Enrollment
60
Registered
2017-07-09
Start date
2017-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chemotherapy. Disorders of initiating and maintaining sleep

Interventions

Intervention 1: Each day, each of the research samples that had the criteria for entering the study, randomly assigned to the group Golmohammadi =, RL = botox, placebo p = and M combination (Golmohamm
Treatment - Other
Placebo
Each day, each of the research samples that had the criteria for entering the study, randomly assigned to the group Golmohammadi =, RL = botox, placebo p = and M combination (Golmohammadi and Stouchet
In the placebo group, distilled water was washed by napkins from the night after chemotherapy at 10 o'clock in the evening with 5 deep breaths for 10 minutes at identical intervals by the patient, and

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Criteria for inclusion in the study: lack of stressful events such as near-death or surgery in the last six months; age range from 18 to 60 years old; having the consent to participate in the study; do not use the herbal remedy in the past month; not having allergic rhinitis, asthma, chronic pulmonary disease, sleep disorders and other chronic diseases that affect the sense of smell; lack of susceptibility to medicinal herbs' not using sleeping pills; take minimum 3-day course of chemotherapy. Exclusion criteria: occurrence of stressful events: close lives, divorces and ... during the study; unwillingness to continue cooperation in the study; use sleep palliative interventions during the study; symptoms of allergy to the fragrance used; having pain during the study (indicated by the patient's question).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sleep quality. Timepoint: Before and 1-3 nights during the intervention. Method of measurement: Standard sleep quality questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahin Tohidi

Hamedan School of Nursing and Midwifery

sh.tohidi8@chmail.ir+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026